Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Other Non-Current Assets (2016 - 2025)

Conmed (CNMD) has disclosed Other Non-Current Assets for 16 consecutive years, with $137.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non-Current Assets rose 17.9% year-over-year to $137.2 million, compared with a TTM value of $137.2 million through Dec 2025, up 17.9%, and an annual FY2025 reading of $137.2 million, up 17.9% over the prior year.
  • Other Non-Current Assets was $137.2 million for Q4 2025 at Conmed, down from $148.3 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $148.3 million in Q3 2025 and bottomed at $93.9 million in Q4 2022.
  • Average Other Non-Current Assets over 5 years is $112.5 million, with a median of $107.3 million recorded in 2022.
  • The sharpest move saw Other Non-Current Assets decreased 4.98% in 2022, then surged 37.84% in 2025.
  • Year by year, Other Non-Current Assets stood at $98.8 million in 2021, then decreased by 4.98% to $93.9 million in 2022, then grew by 2.38% to $96.1 million in 2023, then rose by 21.07% to $116.4 million in 2024, then increased by 17.9% to $137.2 million in 2025.
  • Business Quant data shows Other Non-Current Assets for CNMD at $137.2 million in Q4 2025, $148.3 million in Q3 2025, and $145.1 million in Q2 2025.